Kari Kalliokoski

Has grant

Title of docent

University of Jyväskylä
Country flagFinland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Can we hit on metabolic and cardiovascular diseases with HIT (High-intensity Interval Training)?

Open Date: 2015-01-01

Close Date: 2015-12-31

Articles (7)

Year:

2026

Purpose : This study aimed to measure and compare postexercise glucose uptake (GU) in the left and right ventricular myocardium (LV and RV, respectively) and quadriceps femoris (QF) muscle. Methods : Six recreationally active males (22 [2] y; VO 2 peak 54 [6] mL/kg/min; maximal power 350 [22] W) completed a 30-minute cycling bout. The protocol comprised 10 minutes at 100 W, a ramp to exhaustion (+25 W/min), 1 min passive recovery, then cycling at 75% VO 2 peak to 30 minute GU was quantified with 2-[ 18 F]FDG PET. Results : Postexercise GU in the LV myocardium (14.1 [5.1] μmol/100 g/min) was significantly higher ( P .27). Circulating venous blood lactate concentration was 1.1 (0.5) mmol/L at rest and peaked at 10.4 (2.6) mmol/L postexercise. Peak lactate tended to correlate positively with GU, particularly in the RV ( r = .93, P = .02) and LV ( r = .87, P = .055) myocardium, and to a lesser extent in the QF muscle ( r = .78, P = .12). Conclusion : These findings indicate that the LV myocardium consumes more glucose per unit mass than skeletal muscle after vigorous exercise, whereas the RV shows no such difference.

Year:

2026

Context Postprandial hepatic glycogen synthesis and glycolysis are reduced in hepatic insulin resistance. However, the physiologic interpretation of the reduction in hepatic glucose uptake (GU) during the gold-standard measurement of insulin sensitivity, hyperinsulinemic euglycemic clamp, in insulin resistance is unclear. This is because the peripheral route of glucose and insulin delivery during a clamp study differs greatly from the physiological route. Objective We hypothesized that hepatic GU during hyperinsulinemic euglycemic clamp would predict glycemia during oral glucose tolerance test (OGTT). Design We analyzed cross-sectional data of 120 individuals (70 men and 50 women) who did not have diabetes from the CMgene study cohort. Hepatic GU was measured with [18F]fluorodeoxyglucose ([18F]FDG) and positron emission tomography. Results In a multiple regression analysis, hepatic GU, endogenous glucose production, insulin secretion capacity, and serum triglycerides predicted OGTT glucose area under the curve (P for all <.05), whereas skeletal muscle GU, the antilipolytic insulin index, and insulin clearance were not statistically significant predictors (P > .05). Conclusions Hepatic GU measured during hyperinsulinemic euglycemic clamp is an independent predictor of OGTT glucose area under the curves even when accounting for well-known other factors affecting glycemic control. This finding supports the idea that insulin-mediated hepatic GU, and more broadly, first-pass glucose extraction, have a meaningful contribution to glycemic control. Thus, this measurement provides useful information about hepatic insulin sensitivity in the more physiologic conditions of the OGTT which may be useful when studying the pathophysiology of impaired glucose tolerance and when evaluating potential treatments for impaired glycemic control.

Year:

2025

Background Obesity suppresses bone turnover markers (BTMs) in circulation, and weight loss after metabolic and bariatric surgery (MBS) increases BTM levels. However, the relationship between regional fat distribution and BTMs has not been thoroughly investigated. This study aimed to determine which specific fat compartments - namely abdominal and femoral subcutaneous fat (SF), intraperitoneal fat, extraperitoneal fat, and total visceral fat (VF) - have the greatest impact on circulating BTM levels following weight loss induced by MBS. Methods The study comprised a cohort of individuals with severe obesity ( n = 46) studied before and 6 months after MBS, either sleeve gastrectomy (SG, n = 25) or Roux-en-Y gastric bypass (RYGB, n = 21). Healthy individuals without obesity ( n = 25) served as controls. Regional fat depots were quantified with magnetic resonance imaging. The BTMs included Tartrate-Resistant Acid Phosphatase 5b, C-terminal Telopeptide of Type I Collagen (CTX), Procollagen Type I N-terminal Propeptide (PINP), and Total (TotalOC), Carboxylated (cOC), and Undercarboxylated (ucOC) osteocalcin. Results In the pooled baseline analysis, no significant associations were observed between fat depots and BTMs (all p > 0.05). Postoperatively, distinct patterns emerged between surgical groups. In the SG cohort, femoral SF was inversely associated with cOC levels ( p < 0.05) compared to the RYGB group. Following RYGB, extraperitoneal, intraperitoneal, and total VF were significantly associated with TotalOC, while intraperitoneal and total VF were also negatively associated with ucOC (all p < 0.05) compared to SG. All p -values were adjusted for false discovery rate to correct for multiple comparisons. Conclusions The findings suggest a specific interaction between intraperitoneal, extraperitoneal, and total visceral compartments and bone metabolism following RYGB. These observed relationships highlight the need for clinicians to consider regional fat distribution when assessing bone health in post-MBS patients. ClinicalTrials.gov registration numbers NCT00793143 and NCT01373892.

Year:

2025

High accelerometer-assessed sedentary time associates with metabolic inflexibility measured during hyperinsulinemic-euglycemic clamp in adults with metabolic syndrome, and more light-intensity and total physical activity associate with more metabolic flexibility. Physical activity behaviors may thus play an important role in the regulation of fuel metabolism. This highlights the potential of reduced sedentary time and increased physical activity of any intensity to induce metabolic health benefits and help in disease prevention in risk populations.

Year:

2024

Year:

2023

Background and Aims Clinical management of critical limb-threatening ischaemia (CLTI) is focused on prevention and treatment of atherosclerotic arterial occlusions. The role of microvascular pathology in disease progression is still largely unspecified and more importantly not utilized for treatment. The aim of this explorative study was to characterize the role of the microvasculature in CLTI pathology. Methods Clinical high-resolution imaging of CLTI patients (n = 50) and muscle samples from amputated CLTI limbs (n = 40) were used to describe microvascular pathology of CLTI at the level of resting muscle blood flow and microvascular structure, respectively. Furthermore, a chronic, low arterial driving pressure-simulating ischaemia model in rabbits (n = 24) was used together with adenoviral vascular endothelial growth factor A gene transfers to study the effect of microvascular alterations on muscle outcome. Results Resting microvascular blood flow was not depleted but displayed decreased capillary transit time (P < .01) in CLTI muscles. Critical limb-threatening ischaemia muscle microvasculature also exhibited capillary enlargement (P < .001) and further arterialization along worsening of myofibre atrophy and detaching of capillaries from myofibres. Furthermore, CLTI-like capillary transformation was shown to worsen calf muscle force production (P < .05) and tissue outcome (P < .01) under chronic ischaemia in rabbits and in healthy, normal rabbit muscle. Conclusions These findings depict a progressive, hypoxia-driven transformation of the microvasculature in CLTI muscles, which pathologically alters blood flow dynamics and aggravates tissue damage under low arterial driving pressure. Hypoxia-driven capillary enlargement can be highly important for CLTI outcomes and should therefore be considered in further development of diagnostics and treatment of CLTI.

Year:

2023

Collaborators (16)

Riku Klén

Associate Professor

Turku PET Centre

FINLAND
View details

Pirjo Nuutila

turku university hospital and university of turku

FINLAND
View details

Kirsi Laitinen

Professor, Director (NuFo)

University of Turku

FINLAND
View details

Ilkka H. A. Heinonen

University of Turku

FINLAND
View details

Tiia Koivula

University of Turku

FINLAND
View details

Jarna C. Hannukainen

-

FINLAND
View details

Anna K Kirjavainen

Senior researcher

University of Turku

FINLAND
View details

Carl Johan Sundberg

Karolinska Institutet

SWEDEN
View details

Kaisa Ivaska

University Lecturer, Docent

University of Turku

FINLAND
View details

Petra Korpisalo

Kuopio University Hospital

FINLAND
View details

Miikka-Juhani Honka

Researcher

Turku PET Centre

FINLAND
View details

Greta Juusola

Early career researcher

University of Eastern Finland

FINLAND
View details

Henri Vähä-Ypyä

Ukk Instituutti

FINLAND
View details

Helene Rundqvist

Senior Researcher

Karolinska Institutet

SWEDEN
View details

Harri Hakovirta

Professor

University of Turku

FINLAND
View details

Laura Pekkarinen

University of Turku

FINLAND
View details